There are two major categories of osteoporosis — primary and secondary — but within those categories, at least five to six distinct subtypes exist, each driven by different mechanisms and requiring different treatment approaches. This in-depth analysis of the different types of osteoporosis matters because a 65-year-old woman with postmenopausal bone loss and a 40-year-old man on chronic prednisone have fundamentally different diseases, even though both get labeled “osteoporosis.”
Roughly 200 million people worldwide have osteoporosis, and it causes more than 8.9 million fractures annually — that’s one osteoporotic fracture every 3 seconds. But here’s the problem: up to 30% of osteoporosis cases are secondary, meaning they’re caused by another condition or medication, and many of these go unrecognized. Knowing which type you’re dealing with changes everything — from which lab tests to order to which drug will actually work.
Primary Osteoporosis: The Two Main Subtypes
Primary osteoporosis accounts for roughly 70–80% of all cases. It develops without an identifiable external cause, though hormonal shifts and aging are the driving forces. Historically, it was divided into Type I and Type II using the Riggs classification system.
Type I: Postmenopausal Osteoporosis
This type hits women within 5–20 years after menopause, typically between ages 50 and 70. The mechanism is straightforward: estrogen levels plummet, and estrogen is one of the most powerful natural inhibitors of osteoclast activity (the cells that break down bone). Without it, bone resorption accelerates dramatically.
Women can lose 2–3% of bone mass per year in the first 5–10 years after menopause. The trabecular (spongy) bone is hit hardest, which is why vertebral compression fractures and distal radius (wrist) fractures are the hallmark injuries of Type I osteoporosis.
Type II: Age-Related (Senile) Osteoporosis
This type affects both men and women, generally after age 70. The mechanism is more gradual — a slow decline in osteoblast function (the cells that build bone), reduced calcium absorption in the gut, declining vitamin D levels, and a mild secondary hyperparathyroidism that quietly accelerates bone turnover for decades.
Unlike Type I, Type II affects both cortical and trabecular bone, which is why hip fractures — involving the thick cortical bone of the femoral neck — become so common in this age group. Hip fractures carry a 20–30% one-year mortality rate in elderly patients, making this subtype particularly dangerous.
Idiopathic Osteoporosis
A less common but important primary subtype, idiopathic osteoporosis occurs in premenopausal women, younger men, and even children with no identifiable cause. These patients require thorough workup to rule out secondary causes before this diagnosis is applied.
Secondary Osteoporosis: When Another Condition Is the Culprit
Secondary osteoporosis results from identifiable diseases, medications, or lifestyle factors. It accounts for roughly 20–30% of cases in postmenopausal women and up to 50–60% of cases in men — which is why osteoporosis in a man should always trigger a secondary cause workup.
| Category | Specific Causes | Mechanism of Bone Loss |
|---|---|---|
| Medications | Glucocorticoids (prednisone ≥5 mg/day for ≥3 months), aromatase inhibitors, anticonvulsants, PPIs, heparin | Suppressed osteoblasts, increased osteoclast activity, impaired calcium absorption |
| Endocrine disorders | Hyperthyroidism, hyperparathyroidism, Cushing syndrome, hypogonadism, type 1 diabetes | Excess bone turnover, hormonal imbalance, impaired bone formation |
| GI/Malabsorption | Celiac disease, Crohn’s disease, gastric bypass, chronic liver disease | Reduced calcium and vitamin D absorption |
| Rheumatologic | Rheumatoid arthritis, ankylosing spondylitis, systemic lupus | Chronic inflammation + glucocorticoid use |
| Hematologic | Multiple myeloma, systemic mastocytosis, thalassemia | Direct marrow infiltration, cytokine-mediated bone destruction |
| Lifestyle | Chronic alcohol use (≥3 drinks/day), smoking, prolonged immobilization, anorexia nervosa | Toxic osteoblast suppression, nutritional deficiency, mechanical unloading |
Glucocorticoid-Induced Osteoporosis (GIOP)
This deserves special attention because it’s the most common form of secondary osteoporosis and the most common cause of iatrogenic (doctor-caused) osteoporosis. Bone loss begins within the first 3–6 months of steroid use, with the fastest rate occurring in the first year. Doses as low as 2.5–7.5 mg of prednisone daily increase fracture risk.
What makes GIOP particularly treacherous is that fractures occur at higher T-scores than in primary osteoporosis. A patient on chronic steroids may fracture at a T-score of −1.5, which technically falls in the “osteopenia” range. This is why the American College of Rheumatology recommends earlier intervention for GIOP patients.
How Osteoporosis Is Diagnosed Across All Types
The gold standard is a DEXA scan (Dual-Energy X-ray Absorptiometry), which measures bone mineral density at the hip, spine, and sometimes forearm. Results are reported as a T-score:
- Normal: T-score ≥ −1.0
- Osteopenia: T-score between −1.0 and −2.5
- Osteoporosis: T-score ≤ −2.5
- Severe osteoporosis: T-score ≤ −2.5 with a fragility fracture
The FRAX calculator estimates 10-year fracture probability using clinical risk factors. Treatment is generally recommended when 10-year hip fracture risk exceeds 3% or major osteoporotic fracture risk exceeds 20%.
When secondary osteoporosis is suspected, additional labs are critical: serum calcium, phosphorus, 25-hydroxyvitamin D, PTH, TSH, testosterone (in men), serum protein electrophoresis, 24-hour urine calcium, celiac antibodies, and sometimes bone turnover markers like CTX and P1NP.
Treatment Differs by Type
Not all osteoporosis responds to the same treatment. Bisphosphonates (alendronate, zoledronic acid) are first-line for most primary osteoporosis. But for severe cases or patients who fracture on bisphosphonates, anabolic agents like teriparatide or romosozumab build new bone rather than just slowing breakdown.
For GIOP, the American College of Rheumatology specifically favors bisphosphonates or teriparatide over denosumab as first-line options. For postmenopausal women within 10 years of menopause, hormone replacement therapy remains effective at preventing bone loss, though it’s weighed against cardiovascular and breast cancer risk. In secondary osteoporosis, treating the underlying cause is just as important as treating the bone — fixing the hyperthyroidism, tapering the steroids, or diagnosing the celiac disease.
When to See a Doctor
- You’ve had a fragility fracture (a break from a fall at standing height or less)
- You’re a woman over 65 or a man over 70 who hasn’t had a DEXA scan
- You’ve taken prednisone or equivalent for more than 3 months at any dose
- You’ve lost more than 1.5 inches (4 cm) of height
- You’re a man under 70 or a premenopausal woman with risk factors like low body weight, smoking, family history of hip fracture, or early menopause
- You have a chronic condition known to cause bone loss (see table above)
Frequently Asked Questions
What is the most common type of osteoporosis?
Postmenopausal osteoporosis (Type I primary) is the most common type overall. Among secondary causes, glucocorticoid-induced osteoporosis tops the list. In men specifically, secondary osteoporosis causes account for the majority of cases — up to 60% — which is why a cause workup is always recommended.
Can you have more than one type of osteoporosis at the same time?
Absolutely. A 72-year-old woman with rheumatoid arthritis on long-term prednisone may have Type I (postmenopausal), Type II (age-related), and GIOP (secondary) all contributing simultaneously. This is actually common and one reason some patients lose bone faster than expected.
Is osteoporosis in men different from osteoporosis in women?
Yes, in several important ways. Men have larger bones and never experience the rapid estrogen-drop phase women do at menopause. However, men who develop osteoporosis tend to have worse outcomes — mortality after hip fracture is nearly twice as high in men compared to women. Secondary causes (especially hypogonadism, alcohol use, and glucocorticoids) drive a much higher proportion of male osteoporosis.
Does osteopenia always turn into osteoporosis?
No. Many people with osteopenia never progress to osteoporosis, especially if they maintain adequate calcium (1,000–1,200 mg/day), vitamin D (800–1,000 IU/day), weight-bearing exercise, and avoid modifiable risk factors. However, some osteopenic patients — particularly those with high FRAX scores — do benefit from pharmacologic treatment.
At what age should you start screening for osteoporosis?
The U.S. Preventive Services Task Force recommends DEXA screening for all women at age 65 and for younger postmenopausal women with risk factors. For men, screening is recommended at age 70, or earlier if risk factors are present. There’s no universally agreed-upon guideline for men, so clinical judgment matters here.
